Overview of Dr. Wexler
Dr. Leonard Wexler is a pediatric hematologist and oncologist based in New York City. A graduate from Boston University School of Medicine, his medical training includes internships and residencies at Montefiore Medical Center/Albert Einstein College of Medicine and Jacobi Medical Center. Dr. Wexler also completed a fellowship in pediatric hematology/oncology at the National Cancer Institute/Pediatric Oncology Branch. His research has been published in prestigious publications such as Cancer Research, Urology, and Clinical Cancer Research, and includes a focus on bone and soft tissue sarcomas, particularly rhabdomyosarcoma. He has conducted a clinical trial on high-risk rhabdomyosarcomas, using Irinotecan and Carboplatin. Dr. Wexler has received several awards, notably being named multiple times as one of America's Top Doctors by Castle Connolly.
Office
225 Summit Avenue
Montvale, NJ 07645
Education & Training
- National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1988 - 1990
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1987 - 1988
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1986 - 1987
- Jacobi Medical Center/Albert Einstein College of MedicineInternship, Pediatrics, 1985 - 1986
- Boston University School of MedicineClass of 1985
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 1997 - 2025
- NY State Medical License 1986 - 2025
- NC State Medical License 2020 - 2022
- DC State Medical License 1992 - 1997
- MD State Medical License 1989 - 1995
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2005-2009, 2011, 2013-2014
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- Trends in Location of Death for Individuals With Pediatric Cancer.Urvish Jain, Angelin Tresa Mathew, Bhav Jain, Erin Jay Garbes Feliciano, Edward Christopher Dee
JAMA Pediatrics. 2024-11-01 - Botryoid-type Embryonal Rhabdomyosarcoma: A Comprehensive Clinicopathologic and Molecular Appraisal With Cross-comparison to its Conventional-type Counterpart.Aarti E Sharma, Josephine K Dermawan, Sarah Chiang, Leonard H Wexler, Cristina R Antonescu
The American Journal of Surgical Pathology. 2024-08-30 - Intraoperative radiation therapy for pediatric sarcomas and other solid tumors.Brianna Conte, Dana L Casey, Kathryn R Tringale, Michael P LaQuaglia, J Ted Gerstle
Pediatric Blood & Cancer. 2024-06-01
Journal Articles
- MYOD1-Mutant Spindle Cell and Sclerosing Rhabdomyosarcoma: An Aggressive Subtype Irrespective of Age. A Reappraisal for Molecular Classification and Risk StratificationLeonard H Wexler, Cristina R Antonescu, Michael P LaQuaglia, Narasimhan P Agaram, Nature
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
Anthem Blue Preferred Plus POS
BCBS Alabama PPO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPOGHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust POS-SE
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: